News New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Related Stories AI Cybersecurity MSP News SMB Guardz Report: 9 Out Of 10 SMBs Have Compromised Users as AI-Driven Attacks Reshape the MSP Threat Landscape News Aerospike’s New AI-native Developer Experience Optimized for Rapid, High-quality Coding by Humans and AI Agents News Ankit Tandon Named Vice Chairman of G6 Hospitality as PRISM Doubles Down on North American Growth News Anuma launches private AI with one memory across every leading model News Canada’s Newcomer Children Have an Academic Integration Gap. A Community-Owned Ontario Startup Just Partnered With Three School Boards to Close It News Snail Games USA Expands Publishing Portfolio with the Launch of Above The Snow
